Skip to main content
. 2016 Feb 25;7:225. doi: 10.3389/fpls.2016.00225

Figure 8.

Figure 8

LC-MS/MS Enhanced Product Ion (EPI) scan of sodium borohydride (NaBH4) treated CYP96T1 assays with 4′-O-methylnorbelladine substrate. (A) Chromatograph with the following sample runs top to bottom: N-demethylgalanthamine standard, CYP96T1 assay, CPR assay, assay with no Sf9 cells and CYP96T1 assay without 4'-O-methylnorbelladine. (B) EPI fragmentation pattern of the N-demethylgalanthamine standard peak eluting at 4 min. (C) EPI fragmentation pattern of the N-demethylgalanthamine product in the CYP96T1 assay. (D) EPI fragmentation pattern of epi-N-demethylgalanthamine from the CYP96T1 assay. (E) EPI fragmentation pattern of (10bS,4aR)- and (10bR,4aS)-noroxomaritidine standard reduced to stereoisomeric 8-O-demethylmaritidine. (F) EPI fragmentation pattern of reduced (10bS,4aR)- and (10bR,4aS)-noroxomaritidine product from CYP96T1 assays.